Ivabradine Solution
Brand names: Corlanor
Category: Cardiovascular
FDA status: To Be Discontinued · Last FDA update: Mar 24, 2026 · First posted: Mar 24, 2026 · 1 manufacturers, 1 listed presentations
As of Mar 24, 2026, the FDA lists Ivabradine Solution as being discontinued. Of 1 manufacturer presentations, 1 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Corlanor, Solution, 5 mg/5 mL (NDC 55513-813-28) NDC 55513-813-28 |
Amgen Inc. | Not specified | Discontinuation of the manufacture of the drug product |
Related medications in shortage
Other Cardiovascular medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Ivabradine Solution (FDA data as of Mar 24, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Ivabradine Solution. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/ivabradine-solution.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).